KNBIF (Kane Biotech) EBIT per Share: $-0.01 (TTM As of Mar. 2026)


What is Kane Biotech EBIT per Share?

Kane Biotech KNBIF +5.19% EBIT per Share is $-0.01 as of Mar. 2026. The stock has 6 warning signs investors should review. Among 1,185 Biotechnology companies, Kane Biotech ranks better than 53% on this metric.

Kane Biotech's EBIT per Share for the three months ended in Mar. 2026 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 18.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 16.20% per year. During the past 10 years, the average EBIT per Share Growth Rate was 12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Kane Biotech's EBIT per Share or its related term are showing as below:

KNBIF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -3.6   Med: 12.25   Max: 22.9
Current: 18

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Kane Biotech was 22.90% per year. The lowest was -3.60% per year. And the median was 12.25% per year.

KNBIF's 3-Year EBIT Growth Rate is ranked better than
53% of 1185 companies
in the Biotechnology industry
Industry Median: 15.4 vs KNBIF: 18.00

Kane Biotech's EBIT for the three months ended in Mar. 2026 was $-0.48 Mil.

Kane Biotech  (OTCPK:KNBIF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Kane Biotech EBIT per Share Related Terms

Kane Biotech EBIT per Share Historical Data

* Premium members only.

The historical data trend for Kane Biotech's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech EBIT per Share Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.02 -0.02 -0.02 -0.01

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.00 -0.00 -0.00 -0.00

Kane Biotech EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Kane Biotech's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBIT per Share(A: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-1.875/162.223
=-0.01

Kane Biotech's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.476/181.857
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.01 mean?
Kane Biotech (KNBIF) has a EBIT per Share of $-0.01 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kane Biotech and its competitors. According to the industry distribution chart, Kane Biotech ranks #557 out of 1185 companies in the Biotechnology industry, placing it in the top 47%.
Is Kane Biotech's EBIT per Share too high?
Kane Biotech's current EBIT per Share is $-0.01. Based on the distribution chart, Kane Biotech ranks #557 out of 1185 companies in the Biotechnology industry, which is above the industry midpoint.
How does Kane Biotech's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #557 out of 1185 companies for EBIT per Share. This puts Kane Biotech in the upper half of its industry. The industry median EBIT per Share is 15.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.40, based on 1,185 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kane Biotech and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kane Biotech's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current EBIT per Share of $-0.01. The current EBIT per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current EBIT per Share is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.